Search Results - "Antitubercular agents/therapeutic use"
-
1
Authors: et al.
Source: Nederlands Tijdschrift Voor Tandheelkunde. 132:390-394
-
2
Authors: et al.
Contributors: et al.
Source: The Lancet Child & Adolescent Health, 9, 2, pp. 100-111
Subject Terms: Male, Adolescent, Antitubercular Agents/therapeutic use, Antitubercular Agents, Infant, Multidrug-Resistant/drug therapy, Treatment Outcome, Child, Preschool, Tuberculosis, Multidrug-Resistant, Tuberculosis, Humans, Rifampin/therapeutic use, Female, Rifampin, Pulmonary Diseases - Radboud University Medical Center, Preschool, Child, Antibiotics, Antitubercular
-
3
Authors: et al.
Source: Drugs
Subject Terms: Male, Adult, Antitubercular Agents, Self Administration, Female [MeSH], Adult [MeSH], Humans [MeSH], Infusions, Parenteral [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis/drug therapy [MeSH], Antitubercular Agents/adverse effects [MeSH], Outpatients [MeSH], Male [MeSH], Tuberculosis, Multidrug-Resistant/drug therapy [MeSH], Antitubercular Agents/administration, Germany [MeSH], Original Research Article, Self Administration [MeSH], Treatment Outcome, Germany, Outpatients, Tuberculosis, Multidrug-Resistant, Humans, Tuberculosis, Female, Infusions, Parenteral, Retrospective Studies
-
4
Authors: et al.
Source: Tropical Medicine & International Health. 29:584-593
Subject Terms: Tuberculosis/drug therapy, Male, Adult, Romania, Antitubercular Agents/therapeutic use, Antitubercular Agents, Multidrug-Resistant/drug therapy, Middle Aged, 3. Good health, Young Adult, Cross-Sectional Studies, Tuberculosis, Multidrug-Resistant, Quality of Life, Humans, Tuberculosis, Female, Patient Reported Outcome Measures, Aged
-
5
Authors: et al.
Subject Terms: Antitubercular Agents - adverse effects, Antitubercular Agents - therapeutic use, Drug-Related Side Effects and Adverse Reactions - genetics, Humans, Pharmacogenetics - methods, Pharmacogenomic Testing - methods, Polymorphism, Genetic - genetics, Tuberculosis - drug therapy, Tuberculosis - genetics, Tuberculosis, Multidrug-Resistant - drug therapy, Multidrug-Resistant - genetics
File Description: pdf
Relation: ispartof: Pharmacogenomics spage 207 epage 221 issue 5-6 vol 26; WOS:001512219200001; 991005791873107891; https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12180384160007891/13180384150007891; alma:61MUN_INST/bibs/991005791873107891
-
6
Authors: et al.
Source: Ann Clin Microbiol Antimicrob
Annals of Clinical Microbiology and Antimicrobials, Vol 23, Iss 1, Pp 1-7 (2024)Subject Terms: Male, Adult, 0301 basic medicine, Helminthiasis, Antitubercular Agents, RM1-950, Infectious and parasitic diseases, RC109-216, Microbiology, Ghana, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Tuberculosis, Humans, Animals, Tuberculosis, Pulmonary, IL-6, Protozoan Infections, Co-infections, Coinfection, Interleukin-6, Brief Report, Sputum, Mycobacterium tuberculosis, Middle Aged, QR1-502, Treatment efficacy, Cytokines, Female, Therapeutics. Pharmacology, Male [MeSH], Tuberculosis, Pulmonary/immunology [MeSH], Sputum/microbiology [MeSH], Coinfection/microbiology [MeSH], Female [MeSH], Ghana [MeSH], Adult [MeSH], Helminthiasis/complications [MeSH], Humans [MeSH], Tuberculosis, Pulmonary/complications [MeSH], Mycobacterium tuberculosis/immunology [MeSH], Antitubercular Agents/therapeutic use [MeSH], Middle Aged [MeSH], Coinfection/parasitology [MeSH], Protozoan Infections/complications [MeSH], Animals [MeSH], Cytokines/blood [MeSH], Sputum/parasitology [MeSH], Young Adult [MeSH], Interleukin-6/blood [MeSH], Helminthiasis/immunology [MeSH], Coinfection/immunology [MeSH]
-
7
Authors: et al.
Source: Skouvig Pedersen, O, Holmgaard, F B, Mikkelsen, M K D, Lange, C, Sotgiu, G, Lillebaek, T, Andersen, A B, Wejse, C M & Dahl, V N 2023, 'Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis', The Journal of infection, vol. 87, no. 3, pp. 177-189. https://doi.org/10.1016/j.jinf.2023.06.014
Pedersen, O S, Holmgaard, F B, Mikkelsen, M K D, Lange, C, Sotgiu, G, Lillebaek, T, Andersen, A B, Wejse, C M & Dahl, V N 2023, ' Global treatment outcomes of extensively drug-resistant tuberculosis in adults : A systematic review and meta-analysis ', Journal of Infection, vol. 87, no. 3, pp. 177-189 . https://doi.org/10.1016/j.jinf.2023.06.014Subject Terms: Extensively Drug-Resistant Tuberculosis/drug therapy, Adult, Drug-resistant tuberculosis, Pre-extensively drug-resistant tuberculosis, Antitubercular Agents/therapeutic use, Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, Treatment outcomes, 3. Good health, Tuberculosis, Pulmonary/drug therapy, Treatment Outcome, Pregnancy, Tuberculosis, Multidrug-Resistant, Tuberculosis, Humans, Female, Extensively drug-resistant tuberculosis, Tuberculosis, Multidrug-Resistant/drug therapy, Tuberculosis, Pulmonary
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/37356629
https://pure.au.dk/portal/en/publications/c37fe070-89e9-4a38-9a1c-28f2e379e384
https://curis.ku.dk/ws/files/366986695/1_s2.0_S0163445323003377_main.pdf
https://pure.au.dk/portal/en/publications/c37fe070-89e9-4a38-9a1c-28f2e379e384
https://doi.org/10.1016/j.jinf.2023.06.014
https://pure.au.dk/ws/files/384334091/1-s2.0-S0163445323003377-main.pdf
http://www.scopus.com/inward/record.url?scp=85164367441&partnerID=8YFLogxK -
8
Authors: et al.
Source: Journal of Infection, 86, 5, pp. 520-524
The Journal of infection, vol. 86, no. 5, pp. 520-524Subject Terms: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, Nitroimidazoles, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Humans, Tuberculosis/drug therapy, Antitubercular Agents/pharmacology, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant/drug therapy, Radboud University Medical Center, Tuberculosis, Radboudumc 4: lnfectious Diseases and Global Health Clinical Pharmacy
File Description: application/pdf
-
9
Authors:
Source: The International Journal of Tuberculosis and Lung Disease. 28:163-165
Subject Terms: Pancreatitis, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Tuberculosis, Pancreatitis/drug therapy, Humans, Multidrug-Resistant/drug therapy
-
10
Authors: et al.
Source: BMC Infect Dis
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)Subject Terms: Male, Adult, 0301 basic medicine, Pharmacogenomic Variants, Arylamine N-Acetyltransferase, Antitubercular Agents, HIV Infections, Drug-induced hepatotoxicity, Infectious and parasitic diseases, RC109-216, Polymorphism, Single Nucleotide, Young Adult, 03 medical and health sciences, Humans, Tuberculosis, Cameroon, HIV Infections/complications [MeSH], Polymorphism, Single Nucleotide [MeSH], Acetylation [MeSH], Pharmacogenomic Variants [MeSH], Tuberculosis/drug therapy [MeSH], Antitubercular Agents/adverse effects [MeSH], Male [MeSH], Pharmacogenetics, Tuberculosis/genetics [MeSH], Female [MeSH], Coinfection [MeSH], Adult [MeSH], Tuberculosis/complications [MeSH], Humans [MeSH], Co-infection, HIV, Antitubercular Agents/therapeutic use [MeSH], Middle Aged [MeSH], Chemical and Drug Induced Liver Injury/genetics [MeSH], Arylamine N-Acetyltransferase/genetics [MeSH], HIV Infections/drug therapy [MeSH], Research, Cameroon/epidemiology [MeSH], Young Adult [MeSH], 0303 health sciences, Coinfection, Acetylation, Middle Aged, 3. Good health, Female, Chemical and Drug Induced Liver Injury
Access URL: https://pubmed.ncbi.nlm.nih.gov/39085767
https://doaj.org/article/45dbcd854c574d1a83341fa60c612ae4
https://pure.amsterdamumc.nl/en/publications/627e1e9d-f97c-4563-b045-ddcbdbe975e5
https://doi.org/10.1186/s12879-024-09638-w
https://repository.publisso.de/resource/frl:6519375
https://discovery-pp.ucl.ac.uk/id/eprint/10195425/ -
11
Authors: et al.
Contributors: et al.
Source: The Lancet. 400:1522-1530
Subject Terms: Male, 0301 basic medicine, Antitubercular Agents, Pyrazinamide* / therapeutic use, Levofloxacin, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Tuberculosis, Multidrug-Resistant, Tuberculosis, Humans, Levofloxacin / therapeutic use, Antitubercular Agents / therapeutic use, Linezolid / therapeutic use, Linezolid, 16. Peace & justice, Pyrazinamide, 3. Good health, Multidrug-Resistant* / drug therapy, Treatment Outcome, Combination, Fluoroquinolones / therapeutic use, Female, Drug Therapy, Combination, Fluoroquinolones
Access URL: https://pubmed.ncbi.nlm.nih.gov/36522208
-
12
Authors: et al.
Source: Global Health
Globalization and Health, Vol 20, Iss 1, Pp 1-16 (2024)Subject Terms: 0301 basic medicine, 0303 health sciences, Humans [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis drugs, Tuberculosis/drug therapy [MeSH], Drug Costs [MeSH], Drug costs, Research, Antitubercular Agents/economics [MeSH], Drug supply, Cost analysis, Global Drug Facility, Global Health [MeSH], Tuberculosis, Price trends, Antitubercular Agents, Global Health, Drug Costs, 3. Good health, 03 medical and health sciences, Humans, Public aspects of medicine, RA1-1270
-
13
Authors:
Source: The International Journal of Tuberculosis and Lung Disease. 27:345-347
Subject Terms: Drug Combinations, Antitubercular Agents/therapeutic use, Antitubercular Agents, Isoniazid, Humans, Tuberculosis, Child
-
14
Authors: et al.
Source: The International Journal of Tuberculosis and Lung Disease. 27:335-337
Subject Terms: Diabetes Complications, Diarylquinolines/therapeutic use, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Tuberculosis, Humans, Multidrug-Resistant/complications, Diabetes Complications/complications, Diarylquinolines
Access URL: https://pubmed.ncbi.nlm.nih.gov/37035978
-
15
Authors: et al.
Source: Bach, F, Wejse, C, Storgaard, M & Patsche, C B 2022, 'Is body height a prognostic marker for outcome of tuberculosis treatment?', Infectious Diseases, vol. 54, no. 7, pp. 538-541. https://doi.org/10.1080/23744235.2022.2047777
Subject Terms: 0301 basic medicine, 0303 health sciences, 03 medical and health sciences, Treatment Outcome, Antitubercular Agents/therapeutic use, Tuberculosis, Multidrug-Resistant, Antitubercular Agents, Humans, Tuberculosis, Multidrug-Resistant/drug therapy, Prognosis, Body Height
-
16
Authors:
Source: Eskandari, S K & Akkerman, O W 2024, 'Endobronchial tuberculosis', Lancet Infectious Diseases, vol. 24, no. 5, e343. https://doi.org/10.1016/S1473-3099(24)00057-4
Subject Terms: Humans, Mycobacterium tuberculosis/isolation & purification, Male, Antitubercular Agents/therapeutic use, Tuberculosis, Pulmonary/diagnosis, Bronchial Diseases/microbiology, Bronchoscopy, Female, Tuberculosis/diagnosis
File Description: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pmid/38670683; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/24814786-3760-401d-933d-17bc287368f2; info:eu-repo/semantics/altIdentifier/pissn/1473-3099; info:eu-repo/semantics/altIdentifier/eissn/1474-4457
Availability: https://hdl.handle.net/11370/24814786-3760-401d-933d-17bc287368f2
https://research.rug.nl/en/publications/24814786-3760-401d-933d-17bc287368f2
https://doi.org/10.1016/S1473-3099(24)00057-4
https://pure.rug.nl/ws/files/1049120679/1-s2.0-S1473309924000574-main.pdf
https://www.scopus.com/pages/publications/85190889905 -
17
Authors: et al.
Contributors: et al.
Subject Terms: Humans, Triage/methods, Mycobacterium tuberculosis/drug effects, Cost-benefit analysis, Antitubercular agents/therapeutic use, Tuberculosis, multidrug-resistant/drug therapy, Sputum/microbiology, Rifampin/therapeutic use, Feasibility studies, South Africa, Extensively drug-resistant tuberculosis/drug therapy, Ethiopia, Nigeria, Adult, Administration, oral, NDAS, SDG 3 - Good Health and Well-being, MCC
File Description: application/pdf
Relation: BMJ Open; 308292163; 85211208351; https://hdl.handle.net/10023/30999
-
18
Authors: et al.
Contributors: et al.
Source: Graefe's Archive for Clinical and Experimental Ophthalmology. 260:1641-1650
Subject Terms: Adult, Male, 0301 basic medicine, Antitubercular Agents, Tuberculosis, Ocular, Ocular* / diagnosis, Uveitis, 03 medical and health sciences, 0302 clinical medicine, Choroid Diseases* / diagnosis, Tuberculosis, Humans, Tuberculoma, Choroid Diseases* / drug therapy, Antitubercular Agents / therapeutic use, Retrospective Studies, Tuberculoma* / drug therapy, Choroid Diseases, Middle Aged, Eye neoplasm, Tuberculoma* / diagnosis, 3. Good health, Ocular* / drug therapy, Treatment Outcome, Choroidal tuberculoma, Female
-
19
Authors: et al.
Source: Muhammed, H, Jain, A, Pattanaik, S S, Chatterjee, R, Naveen, R, Kabeer, H, Gupta, L, Misra, D P, Agarwal, V, Lawrence, A, Misra, R & Aggarwal, A 2021, 'Clinical spectrum of active tuberculosis in patients with systemic lupus erythematosus', Rheumatology International, vol. 41, no. 12, pp. 2185-2193. https://doi.org/10.1007/s00296-021-04933-0
Subject Terms: Tuberculosis/drug therapy, Adult, Male, Lupus Erythematosus, Lupus Erythematosus, Systemic/epidemiology, Antitubercular Agents/therapeutic use, Mycobacterium tuberculosis/isolation & purification, Antitubercular Agents, India, Mycobacterium tuberculosis, Systemic/epidemiology, 3. Good health, India/epidemiology, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Prevalence, Humans, Lupus Erythematosus, Systemic, Tuberculosis, Female, Retrospective Studies
-
20
Authors: et al.
Source: Infection
Subject Terms: Male, 0301 basic medicine, 0303 health sciences, Incidence, Paradoxical response, Antitubercular Agents, Review, Tuberculosis, Lymph Node, Female [MeSH], Tuberculosis/epidemiology [MeSH], Recurrence, Tuberculosis/diagnosis [MeSH], Humans [MeSH], Paradoxical reaction, Incidence [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis, Lymph Node/diagnosis [MeSH], Recurrence [MeSH], Paradoxical upgrading, Tuberculosis/drug therapy [MeSH], Male [MeSH], Tuberculosis, Tuberculosis, Lymph Node/drug therapy [MeSH], Lymph node, 03 medical and health sciences, Humans, Female
Nájsť tento článok vo Web of Science 
Full Text Finder 
Full Text